| Protein design of an HIV-1 entry inhibitor MJ Root, MS Kay, PS Kim Science 291 (5505), 884-888, 2001 | 581 | 2001 |
| Potent D-peptide inhibitors of HIV-1 entry BD Welch, AP VanDemark, A Heroux, CP Hill, MS Kay Proceedings of the National Academy of Sciences 104 (43), 16828-16833, 2007 | 330 | 2007 |
| A stiffness switch in human immunodeficiency virus N Kol, Y Shi, M Tsvitov, D Barlam, RZ Shneck, MS Kay, I Rousso Biophysical journal 92 (5), 1777-1783, 2007 | 284 | 2007 |
| Inhibiting HIV fusion with a β-peptide foldamer OM Stephens, S Kim, BD Welch, ME Hodsdon, MS Kay, A Schepartz Journal of the American Chemical Society 127 (38), 13126-13127, 2005 | 228 | 2005 |
| Inhibiting HIV fusion with a β-peptide foldamer OM Stephens, S Kim, BD Welch, ME Hodsdon, MS Kay, A Schepartz Journal of the American Chemical Society 127 (38), 13126-13127, 2005 | 228 | 2005 |
| Packing interactions in the apomyglobin folding intermediate MS Kay, RL Baldwin Nature structural biology 3 (5), 439-445, 1996 | 225 | 1996 |
| Design of a Potent d-Peptide HIV-1 Entry Inhibitor with a Strong Barrier to Resistance BD Welch, JN Francis, JS Redman, S Paul, MT Weinstock, JD Reeves, ... Journal of virology 84 (21), 11235-11244, 2010 | 201 | 2010 |
| RETRACTED: The hepcidin-binding site on ferroportin is evolutionarily conserved I De Domenico, E Nemeth, JM Nelson, JD Phillips, RS Ajioka, MS Kay, ... Cell metabolism 8 (2), 146-156, 2008 | 184 | 2008 |
| RETRACTED: The hepcidin-binding site on ferroportin is evolutionarily conserved I De Domenico, E Nemeth, JM Nelson, JD Phillips, RS Ajioka, MS Kay, ... Cell metabolism 8 (2), 146-156, 2008 | 184 | 2008 |
| RETRACTED: The hepcidin-binding site on ferroportin is evolutionarily conserved I De Domenico, E Nemeth, JM Nelson, JD Phillips, RS Ajioka, MS Kay, ... Cell metabolism 8 (2), 146-156, 2008 | 184 | 2008 |
| Structure and stability of a second molten globule intermediate in the apomyoglobin folding pathway. SN Loh, MS Kay, RL Baldwin Proceedings of the National Academy of Sciences 92 (12), 5446-5450, 1995 | 166 | 1995 |
| One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV … PW Denton, F Othieno, F Martinez-Torres, W Zou, JF Krisko, E Fleming, ... Journal of virology 85 (15), 7582-7593, 2011 | 147 | 2011 |
| Synthesis and folding of a mirror-image enzyme reveals ambidextrous chaperone activity MT Weinstock, MT Jacobsen, MS Kay Proceedings of the National Academy of Sciences 111 (32), 11679-11684, 2014 | 136 | 2014 |
| Protease‐resistant peptide design—empowering nature's fragile warriors against HIV MT Weinstock, JN Francis, JS Redman, MS Kay Peptide Science 98 (5), 431-442, 2012 | 107 | 2012 |
| Steric accessibility of the HIV-1 gp41 N-trimer region AE Hamburger, S Kim, BD Welch, MS Kay Journal of Biological Chemistry 280 (13), 12567-12572, 2005 | 97 | 2005 |
| Cooperativity of folding of the apomyoglobin pH 4 intermediate studied by glycine and proline mutations Y Luo, MS Kay, RL Baldwin Nature Structural Biology 4 (11), 925-930, 1997 | 85 | 1997 |
| A helping hand to overcome solubility challenges in chemical protein synthesis MT Jacobsen, ME Petersen, X Ye, M Galibert, GH Lorimer, V Aucagne, ... Journal of the American Chemical Society 138 (36), 11775-11782, 2016 | 79 | 2016 |
| Virion stiffness regulates immature HIV-1 entry HB Pang, L Hevroni, N Kol, DM Eckert, M Tsvitov, MS Kay, I Rousso Retrovirology 10, 1-11, 2013 | 76 | 2013 |
| Specificity of native-like interhelical hydrophobic contacts in the apomyoglobin intermediate MS Kay, CHI Ramos, RL Baldwin Proceedings of the National Academy of Sciences 96 (5), 2007-2012, 1999 | 69 | 1999 |
| Molecular architecture of a dynamin adaptor: implications for assembly of mitochondrial fission complexes S Koirala, HT Bui, HL Schubert, DM Eckert, CP Hill, MS Kay, JM Shaw Journal of cell biology 191 (6), 1127-1139, 2010 | 54 | 2010 |
James M FulcherStaff Scientist, Pacific Northwest National LabVerified email at pnnl.gov
